Decision: Favourable
Study Title:
A 52-week, randomised, double-blind, double-dummy, parallel group, multicentre, non-inferiority study assessing exacerbation rate, additional measures of asthma control and safety in adult and adolescent severe asthmatic participants with an eosinophil
NREC Code:
21-NREC-CT-170
Decision:
Favourable
Meeting Date:
12/12/2021
Study Type:
CT application
Principal Investigator:
Dr Desmond Michael Murphy
PI Institution:
Cork University Hospital
Sponsor:
IQVIA on behalf of GlaxoSmithKline Research & Development Limited